CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 15 Issue 3

Can a Modular Approach to Cleanroom Technology Deliver Flexible Sterile Manufacturing Capacity?

Trista Hager, Vice President of Sales at AES Clean Technology, explores the challenges facing pharmaceutical manufacturers in expanding their cleanroom capacity to m...
Continue Reading →
Volume 15 Issue 3

At last! The Advent of Better Software Application UX to Manage Critical Manufacturing Processes in Highly Regulated Industries

For too long, professionals in the manufacturing industry have had to cope with software applications that are designed more for function than usability despite the ...
Continue Reading →
Volume 15 Issue 3

Tablet Coating: Optimal Uniformity and Flexibility Tablet Coater Saves Resources

Tablets are the most important oral dosage form in the pharmaceutical industry. The advantages of tablets are numerous. First and foremost is the ability to precisel...
Continue Reading →
Volume 15 Issue 3

How to Make the Grade in Pharma Manufacturing

The current era in pharmaceutical manufacturing is defined by challenging market demands and stricter regulations, particularly with new, more comprehensive GMP stan...
Continue Reading →
Volume 15 Issue 3

High Potent Manufacture

The global market for drug products containing highly potent active pharmaceutical ingredients (HPAPIs) is currently on a growth fast track. Data indicates a Compoun...
Continue Reading →
Volume 15 Issue 3

Addressing the Challenges of Serialisation

Drug counterfeiting poses a significant threat to the pharmaceutical industry, risking patient safety and undermining the integrity of the global supply chain. As il...
Continue Reading →
Volume 15 Issue 3

What Does the Future Hold for Delayed Release Empty Hard Capsules?

An Exploration of Enteric Release Capsules in the Nutraceutical and Pharmaceutical Markets The term “delayed-release” formulation refers to finished dosage form t...
Continue Reading →
Volume 15 Issue 3

Chemical Recycled ABS Materials for the Transition to a Circular Economy Model

The demand for new, sustainable ABS materials for drug delivery device applications is growing in the healthcare sector. However, because of the risk of cross-contam...
Continue Reading →
Volume 15 Issue 3

Navigating the Shift in Pharmaceutical Packaging:

Beyond Traditional Structures Towards Healthier and More Sustainable Future In the past the choice of packaging strategy in pharmaceutical industry was often pure...
Continue Reading →
Volume 15 Issue 3

Taking Healthcare Out of the Hospital: How Device Design Can Empower Users

From point-of-care diagnostics to auto-injectors, medical devices are increasingly enabling more procedures and healthcare activities to be conducted outside of the ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026